Is CP 16171 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use CP 16171? Is CP 16171 safe for nursing mother and child? Does CP 16171 extracts into breast milk? Does CP 16171 has any long term or short term side effects on infants? Can CP 16171 influence milk supply or can CP 16171 decrease milk supply in lactating mothers?
CP 16171 lactation summary
- DrLact safety Score for CP 16171 is 1 out of 8 which is considered Safe as per our analyses.
- A safety Score of 1 indicates that usage of CP 16171 is mostly safe during lactation for breastfed baby.
- Our study of different scientific research also indicates that CP 16171 does not cause any serious side effects in breastfeeding mothers.
- Most of scientific studies and research papers declaring usage of CP 16171 safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About CP 16171 usage in lactation
It is excreted in breast milk in clinically non-significant amount and no problems have been observed in infants whose mothers took this medication. Levels in plasma and urine of such infants were undetectable. Having published less quantity of studies than with other drugs of the same group, safer alternatives may be preferable, especially in the neonatal period and in case of prematurity. The American Academy of Pediatrics rates it as usually compatible with breastfeeding.
Answer by DrLact: About CP 16171 usage in lactation
Low amounts of CP 16171 in milk and failure to detect CP 16171 or its metabolites in the urine of 2 older infants indicates that it would not be expected to cause adverse effects in older breastfed infants. Because there is no published experience with CP 16171 during breastfeeding in the newborn period, shorter-acting agents may be preferred while nursing a newborn or preterm infant.
CP 16171 Side Effects in Breastfeeding
No adverse effects were found in the breastfed infant of a patient receiving 20 mg of CP 16171 daily for 4 months starting the 9th month postpartum.[1]Four infants 3 to 4.5 months of age remained healthy during long-term therapy of their mothers with CP 16171 20 mg daily.[2]
Alternate Drugs
Flurbiprofen(Safe)
Naproxen(Low Risk)
Dipyrone(Low Risk)
Fenoprofen(Safe)
Nabumetone(Low Risk)
Ketoprofen(Safe)
Meloxicam(Low Risk)
Aspirin(Low Risk)
Etodolac(Low Risk)
Mefenamic Acid(Safe)
Oxaprozin(Low Risk)
Diflunisal(Low Risk)
Meclofenamate(Low Risk)
Diclofenac(Safe)
Ketorolac(Safe)
Tolmetin(Safe)
Celecoxib(Safe)
Indomethacin(Safe)
Sulindac(Low Risk)
Ibuprofen(Safe)
Piroxicam(Safe)
Flurbiprofen(Safe)
Naproxen(Low Risk)
Dipyrone(Low Risk)
Fenoprofen(Safe)
Nabumetone(Low Risk)
Ketoprofen(Safe)
Meloxicam(Low Risk)
Aspirin(Low Risk)
Etodolac(Low Risk)
Mefenamic Acid(Safe)
Oxaprozin(Low Risk)
Diflunisal(Low Risk)
Meclofenamate(Low Risk)
Diclofenac(Safe)
Ketorolac(Safe)
Tolmetin(Safe)
Celecoxib(Safe)
Indomethacin(Safe)
Sulindac(Low Risk)
Ibuprofen(Safe)
Piroxicam(Safe)